共 88 条
[1]
Bielecka-Dabrowa A(2020)Cachexia, muscle wasting, and frailty in cardiovascular disease Eur J Heart Fail 22 2314-2326
[2]
Nielsen RE(2021)Cardiovascular disease in patients with severe mental illness Nat Rev Cardiol 18 136-145
[3]
Banner J(2021)Cardiovascular statistics 2021 Prog Cardiovasc Dis 67 114-115
[4]
Jensen SE(2020)Assessing stable coronary artery disease Cleve Clin J Med 87 713-2301
[5]
Lavie CJ(2021)Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging Curr Probl Cardiol 46 2289-278
[6]
Modarressi T(2020)Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque J Am Coll Cardiol 76 274-2571
[7]
Katta N(2020)The value of cytochrome P4502C19 gene assay for antiplatelet therapy after PCI in stable angina patients with left main coronary artery lesions Nan Fang Yi Ke Da Xue Xue Bao 40 2569-1744
[8]
Stone GW(2020)Ticagrelor or prasugrel for platelet inhibition in acute coronary syndrome patients: the ISAR-REACT 5 trial J Am Coll Cardiol 76 1737-515
[9]
Zheng X(2020)Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Lancet 396 510-978
[10]
Wu L(2020)Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel? Thromb Res 196 963-1211